Skip to content

Company information lookup

CYNATA THERAPEUTICS LIMITED (CYP)

Stem cell and regenerative medicine development.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
CYP 0.410 -1.2% 0.400 0.410 0.410 0.410 0.410 5,190
(Status - RE)

CYNATA THERAPEUTICS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code CYP
Securities
Official Listing Date 20 December, 2007
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.cynata.com
Registered Office Address Suite 1, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3143
Head Office Telephone (03) 9824 5254
Head Office Fax (03) 9822 7735
Share Registry SECURITY TRANSFER REGISTRARS PTY. LIMITED
770 CANNING HIGHWAY, APPLECROSS, WA, AUSTRALIA, 6153
Share Registry Telephone (08) 9315 2333
Directors / Senior Management
Dr Stewart Washer (Executive Chairman)
Dr Ross Macdonald (Managing Director, CEO)
Mr Howard Digby (Non Exec. Director)
Mr Peter Webse (Non Exec. Director)
Company Secretary Mr Peter Webse
Principal Activities Stem cell and regenerative medicine development.

CYNATA THERAPEUTICS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
31/07/2014 asterix Activity Report & Appendix 4C 7 PDF
28/07/2014 asterix CYP Contracts UW to Advance Cymerus Product Development 1 PDF
14/07/2014 asterix Contracts Leading CRO to Conduct Cymerus Preclinical Studies 1 PDF
11/06/2014   Cynata Announces Partnership Agreement 2 PDF
02/06/2014   Leading Brokerage Initiates Cynata Resarch Coverage 1 PDF
29/05/2014   Appendix 3B - Issue of Unlisted Options 12 PDF
22/05/2014   Appendix 3Y - Stewart Washer 2 PDF
22/05/2014   Appendix 3Y - Ross Macdonald 2 PDF
19/05/2014   Vesting of Unlisted Options 1 PDF
13/05/2014   CYP to Participate in Major International Stem Cell Conf 1 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
30 Jul 2014 0.415 -1.19% 0.430 0.410 94,629
29 Jul 2014 0.420 -2.33% 0.430 0.420 7,808
28 Jul 2014 0.430 4.88% 0.430 0.370 71,811
25 Jul 2014 0.410 2.5% 0.410 0.400 135,000
24 Jul 2014 0.400 -1.23% 0.405 0.400 111,750

* Volume of shares shown represents only those shares traded on ASX.

CYNATA THERAPEUTICS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security CYP. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security CYP

Warrants & Structured Products

No warrants & Structured Products are available over the security CYP

ASX CFDs

No Contracts For Differences are available over the security CYP